Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bridgebio Pharma Inc
(NQ:
BBIO
)
30.18
-0.86 (-2.77%)
Streaming Delayed Price
Updated: 1:29 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bridgebio Pharma Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
BridgeBio Pharma Inc. (NASDAQ: BBIO) is a Stock Spotlight on 8/18
August 18, 2023
Via
Investor Brand Network
4 Analysts Have This to Say About BridgeBio Pharma
August 14, 2023
Via
Benzinga
Wall Street Thinks BridgeBio Pharma Could Rise Over 40% -- But Will It?
August 09, 2023
Its potential upcoming drug launch might not be enough.
Via
The Motley Fool
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
August 03, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
Expert Ratings for BridgeBio Pharma
July 18, 2023
Via
Benzinga
7 A-Rated Stocks for Your August Buy List
August 03, 2023
August is shaping up to be a great month for the stock market. Now you just need to make sure you own these A-rated stocks.
Via
InvestorPlace
BridgeBio Pharma Announces Opportunity for Accelerated Approval Pathway in Limb-girdle Muscular Dystrophy Type 2I (LGMD2I/R9) Based on Glycosylated Alpha-dystroglycan (⍺DG) Levels and Announces First Patient Dosed in FORTIFY Phase 3 Study
July 31, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
Could This Stock Be the Next Biotech Buyout?
July 31, 2023
A buyout deal recently pushed Reata Pharmaceuticals stock 53% higher in a single trading session, leading investors to wonder who's next.
Via
The Motley Fool
Why Shares of BridgeBio Pharma Skyrocketed This Week
July 21, 2023
The biotech company saw strong results in a phase 3 trial.
Via
The Motley Fool
Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review
July 21, 2023
But all the major indexes are at or near 15-month highs.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
July 18, 2023
Via
Benzinga
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 18, 2023
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
Crude Oil Falls; GreenPower Motor Company Shares Spike Higher
July 17, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 0.25% on Monday. The Dow traded up 0.25% to 34,596.04 while the NASDAQ rose 0.92% to 14,243.64. The S&P 500, also rose,...
Via
Benzinga
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
July 17, 2023
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%.
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
July 17, 2023
Via
Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 17, 2023
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...
Via
Benzinga
BridgeBio (NASDAQ: BBIO) Announces Exceptionally Positive Outcomes in Phase 3 Study of Acoramidis
July 17, 2023
BridgeBio Pharma (NASDAQ: BBIO), a leading biopharmaceutical company, announced significant outcomes from the ATTRibute-CM, their Phase 3 study of acoramidis,
Via
Spotlight Growth
Nasdaq Gains 100 Points; Guaranty Bancshares Posts Upbeat Results
July 17, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Monday. The Dow traded up 0.19% to 34,574.01 while the NASDAQ rose 0.71% to 14,214.50. The S&P...
Via
Benzinga
Why Are Telecom Stocks Down Today?
July 17, 2023
Telecom stocks aren't doing so how on Monday after several players in the space were hit by downgrades and lowered price targets from Citi.
Via
InvestorPlace
BridgeBio Launches 64% Higher, Pulling Alnylam And Ionis With It, On A 'Best-Case' In Heart Disease
July 17, 2023
The companies are working on treatments for a leading cause of heart failure.
Via
Investor's Business Daily
BridgeBio Pharma Inc. (NASDAQ: BBIO) Records 52-Week High Monday Morning
July 17, 2023
Via
Investor Brand Network
Why Is BridgeBio (BBIO) Stock Up 63% Today?
July 17, 2023
BridgeBio Pharma (BBIO) stock is climbing higher on Monday as investors react to results from a recent Phase 3 clinical trial.
Via
InvestorPlace
US Stocks Edge Higher; NY Empire State Manufacturing Index Falls In July
July 17, 2023
U.S. stocks traded slightly higher this morning, with the Dow Jones moving higher by around 20 points on Monday. Following the market opening Monday, the Dow traded up 0.06% to 34,529.57 while the...
Via
Benzinga
You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers
July 17, 2023
Big gains are afoot even as the markets prepare for a flat open.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 17, 2023
Via
Benzinga
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket
July 17, 2023
Gainers
Via
Benzinga
BridgeBio Pharma Shares Are Shooting Higher Today - Here's Why
July 17, 2023
BridgeBio Pharma Inc (NASDAQ: BBIO) released results from ATTRibute-CM Phase 3 study of acoramidis in transthyretin
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 17, 2023
It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!
Via
InvestorPlace
Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 17, 2023
U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.